Skip Nav Destination
First Edition
Research Article February 28 2025
BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice
Research Article February 26 2025
Targeting the DNA Damage Response through TBL1X in Mantle Cell Lymphoma
Research Article February 26 2025
Characterization and Treatment Outcomes of Malignant Histiocytoses in a Retrospective Series of 141 Cases in France
Camille Bigenwald, Dr,Damien Roos-Weil,Arnaud Pages,Zofia Hélias-Rodzewicz,Christiane Copie-Bergman,Marzieh Nashvi,Pierre khneisser,Marie-Cécile Parrens,Alexandra Traverse-Glehen,Isabelle Ray-Coquard,Loic Ysebaert,Tony Marchand,Jérome Razanamahery,Frédéric Charlotte,Antoine Neel,Gandhi Damaj,Jeremie Dion,Eve Marie Nazal-Traissac,Stéphanie Tardy,Geraldine Salmeron,Hélène Monjanel,Ahmed Iobaih,Sebastien Heritier,Julien Haroche, MD, PhD,Jean Donadieu,Jean-Francois Emile
Letter February 24 2025
Gastrointestinal toxicity of Gemtuzumab Ozogamicin: Real-life data from the AMLCG, SAL and CELL study groups
Ricarda Knabe,Philippe Muller,Christoph Schliemann,Maher Hanoun,Julia Marie Unglaub,Barbora Weinbergerová,Jiri Mayer,Carolin Krekeler,Stefan W Krause,Martin Kaufmann,Sabrina Kraus,Björn Steffen,Franziska Modemann,Marion Subklewe,Veit L. Bücklein,Wolfgang G. Kunz,Martina Rudelius,Michael von Bergwelt-Baildon,Katja Gutmair,Eva Hoster,Tobias Herold,Christoph Röllig,Karsten Spiekermann
Letter February 24 2025
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study
Research Article February 21 2025
Improved survival with model-based dosing of anti-thymocyte globulin in pediatric hematopoietic cell transplantation
Rick Admiraal,Stefan Nierkens,Marc B Bierings,Mirjam E Belderbos,Alwin D. R. Huitema,Robbert GM Bredius,Yilin Jiang,Kevin J. Curran,Andromachi Scaradavou,Maria I. Cancio,Elizabeth Klein,Wouter J Kollen,Dorine Bresters,Friso G. Calkoen,Birgitta Versluijs,C. Michel Zwaan,Jaap Jan Boelens,Caroline A. Lindemans
Research Article February 21 2025
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa
William Frank Mawalla, Dr,Caroline Achola,Hadijah Nabalende,Isaac Otim,Ismail Legason,Martin David Ogwang,Pamella Mwa Aol, PA,Godlove William Sandi,Hadija Mwamtemi,Salama Omari Mahawi, MD,Elifuraha Mkwizu,Philomena G Lyamuya,Jacqueline Peter Kamanga,Kristin M.S. Schroeder,Paul Shadrack Ntemi,Clara Claudius Chamba,Dimitris V. Vavoulis,Liz Morrell,Lulu Fred Chirande,Anna Schuh
Research Article February 21 2025
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: Focus on the very early period and Omicron era
Letter February 21 2025
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Letter February 20 2025
Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study
Research Article February 19 2025
Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in B cells
Research Article February 19 2025
Improved Outcome and Therapeutic Directions in Pediatric Therapy-related AML: Recommendations by the AML-BFM Study Group
Letter February 19 2025
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
Reid Shaw,James J. Yoon,Hannah Johnston,Marta B. Davidson,Alexa J. Siddon,Rory M. Shallis,Evan Chris Chen,Madelyn Burkart,Timothy S. Oh,Sunil Girish Iyer,Ellen Madarang,Chandrasekar Muthiah,Joshua Kassner,Raajit K. Rampal,Guru Subramanian Guru Murthy,Terrence J Bradley,Yasmin Abaza,Jacqueline S. Garcia,Vikas Gupta,Kristen M. Pettit,Olatoyosi Odenike,Anand A Patel
Research Article February 14 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry
Sheila K Pierson,Joshua D Brandstadter,Drew Torigian,Adam Bagg,Mary Jo Lechowicz,Daisy Alapat, MD,Corey Casper,Amy Chadburn,Shanmuganathan Chandrakasan,Angela Dispenzieri,Alexander Fosså,Christian Hoffmann,Makoto Ide,Razelle Kurzrock,Sudipto Mukherjee,Sunita D. Nasta,José-Tomás Navarro,Ariela Noy,Eric Oksenhendler,Mateo Sarmiento Bustamante,Saishravan Shyamsundar,Matthew J Streetly,Raymond Siu Ming Wong,Lu Zhang,Megan S Lim,Gordan Srkalovic,Frits van Rhee,David C Fajgenbaum
Research Article February 14 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T cell lymphoma
Review Article February 14 2025
Fedratinib in 2025 and Beyond: Indications and Future Applications
Research Article February 14 2025
In Vitro Studies of Human Erythropoiesis Using a 3D Silk-Based Bone Marrow Model That Generates Erythroblastic Islands
Research Article February 12 2025
Late-Onset Telomere Biology Disorders: Clinical Insights and Treatment Outcomes from a Retrospective Registry Cohort
Mareike Tometten,Fabian Beier,Martin Kirschner,Yannic Schumacher,Jeanette Walter,Margherita Vieri,Kim Kricheldorf,Alexander Röth,Uwe Platzbecker,Markus P. Radsak,Phillippe Schafhausen,Selim Corbacioglu,Britta Höchsmann,Stefan Balabanov,Claas Heinrich Hinze,Jörg Chromik,Michael Heuser,Michael Kreuter,Marcin W Wlodarski,Miriam Elbracht,Ingo Kurth,Steffen Koschmieder,Jens Peter Panse,Robert Meyer,Tim H. Brümmendorf
Research Article February 12 2025
Mitigating T-Cell Mitochondrial Dysfunction in CLL to Augment CAR T-Cell Therapy: Evaluation in an Immunocompetent Model
Letter February 12 2025
Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicluecel in Patients with Multiple Myeloma
Research Article February 10 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates
Research Article February 10 2025
Single-cell dynamics of breakthrough toxicities following anakinra prophylaxis for axicabtagene ciloleucel in lymphoma
Matthew J. Frigault,Estelle Yao,Trisha R Berger,Marc Wehrli,Kathleen M.E. Gallagher,Nora Horick,Charlotte E Graham,Caron A. Jacobson,Yi-Bin Chen,Mark B. Leick,Zachariah DeFilipp,Areej El-Jawahri,P. Connor Connor Johnson,Maria Dolaher,Katelin Katsis,Austin I. Kim,Jennifer L. Crombie,Reid W. Merryman,Daniella Cook,Michael Trailor,Hana Cho,Richard Jeffrey, III,Rhine R. Shen,Simone Filosto,Jenny Nater,Gad Getz,Nicholas J Haradhvala,Marcela V. Maus
Research Article February 10 2025
Post Transplant Cyclophosphamide as GvHD Prophylaxis in Patients Receiving Mismatched Unrelated HCT: the PHYLOS trial.
Annamaria Raiola,Benedetto Bruno,Antonio Maria Risitano,Federico Mosna, Dr,Irene Maria Cavattoni,Francesco Onida,Giorgia Natascia Saporiti,Francesca Patriarca,Marta Lisa Battista,Vincenzo Pavone,Anna Mele, MD,Patrizia Chiusolo,Simona Sica,Barbara Loteta,Carmen di Grazia,Angelo Michele Carella,Dalila Salvatore,Enrico Morello,Alessandro Leoni,Luisa Giaccone,Paolo Bernasconi,Elisabetta Terruzzi,Nicola Mordini,Carlo Borghero,Francesco Zallio,Mario Luppi,Anna Grassi,Attilio Olivieri,Eugenia Piras,Nicoletta Sacchi,Giovannino Ciccone,Anna Castiglione,Eliana Degrandi,Emanuele Angelucci,Massimo Martino,Francesca Bonifazi
Research Article February 10 2025
Randomized Phase II Study to Assess the Role of Single-Agent Nivolumab to Maintain Remission in Acute Myeloid Leukemia
Athalia Rachel Pyzer,Laura W Dillon,Elad Sharon,Theodore G Karrison,Yuanyuan Zha,Noreen Fulton,Gege Gui,Georgia M Andrew,Howard Streicher,Kendra L. Sweet,George Yaghmour,Jane Jijun Liu,Brian A. Jonas,Aaron D Schimmer,Steven Grant,Amer M. Zeidan,Gerhard C. Hildebrandt,Christopher H Lowrey,Ryan J Mattison,Neil Palmisiano,Amandeep Salhotra,Dimitrios Tzachanis,Maria R Baer,Tara L. Lin,Prapti A. Patel,Helen Chen,Walter Stadler,Olatoyosi Odenike,Richard A Larson,Thomas F Gajewski,Christopher S Hourigan,Wendy Stock,Hongtao Liu
Research Article February 10 2025
Cellular and biochemical heterogeneity contributes to the phenotypic diversity of transfusion-dependent beta thalassemia
Konstantina Theocharaki,Alkmini T Anastasiadi, Dr.,Sophia Delicou,Vassilis L Tzounakas,Ioanna Barla,Stella Rouvela,Evgenia Kazolia,Georgia Tzafa,George Mpekoulis,Theodore Gousdovas,Efthymia Pavlou,Ioannis V Kostopoulos,Athanassios D Velentzas,Nikolaos Simantiris,Aikaterini Xydaki,Niki Vassilaki,Ersi Voskaridou,Ioanna-Katerina Aggeli,Efrosyni Nomikou,Ourania Tsitsilonis,Efstathia G. Papageorgiou,Nikolaos Thomaidis,Evagelos Gikas,Marianna Politou,Veroniki Komninaka,Marianna H Antonelou
Research Article February 6 2025
Metabolically Aberrant Extracellular Mitochondria Induce Oxidative Endotheliopathy in Traumatic Brain Injury
Review Article February 6 2025
FITNESS ASSESSMENT IN ACUTE MYELOID LEUKEMIA: RECOMMENDATIONS FROM AN EXPERT PANEL ON BEHALF OF EUROPEAN LEUKEMIA NET
Adriano Venditti,Raffaele Palmieri,Luca Maurillo,Christoph Röllig,Agnieszka Wierzbowska,David C. de Leeuw,Fabio Efficace,Antonio Curti,Lok Lam Ngai,Jesse M. Tettero,Lionel Adès,Antonio M Almeida,Lars Bullinger,Mike Dennis,Jordi Esteve,Felicetto Ferrara,Michael Heuser,Gerwin A Huls,Michael Lübbert,Priyanka Mehta,Pau Montesinos,Thomas Pabst,Christian Récher,Giuseppe Rossi,Nigel H. Russell,Jorge Sierra,Reinhard Stauder,Norbert Vey,Roland B. Walter,Eunice S Wang,Samantha Nier,Carolina Garcez Martins,Gert J Ossenkoppele
Letter February 5 2025
Targeting RNA Modification and Mitochondrial Metabolism Crosstalk in Leukemic Stem Cells with CDK7 Inhibitor TGN-1062
HyunJun Kang,Lianjun Zhang,Mohan R Kaadige,Melissa Valerio,Dinh Hoa Hoa Hoang,Trason Thode,Alexis Weston,Khyatiben V. Pathak,Lokesh Nigam,Nathaniel P Hansen,Brooke Lovell,Yuriy Shostak,Wei Li,Lucy Y. Ghoda,Zhuo Li,Bin Zhang,Jianjun Chen,Patrick Pirrotte,Ya-Huei Kuo,Sunil Sharma,Guido Marcucci,Le Xuan Truong Truong Nguyen
Letter February 5 2025
Supernumerary ring chromosome 1 syndrome leads to fusion-driven B-cell Acute Lymphoblastic Leukemia in monozygotic twins
Jesús Gutiérrez-Abril,Gunes Gundem,Elise Fiala,Konstantinos Liosis,Noushin Farnoud,Dan Leongamornlert,Anu Amallraja,Juan E. Esteban Arango Ossa,Dylan Domenico,Max Fine Levine,Juan Santiago Medina-Martínez,Emily Stockfisch,Daoqi You,Michael Francis Walsh,Sylwia Jasinski,Andrew L Kung,Neerav N. Shukla,William L. Carroll,Elli Papaemmanuil
Research Article February 5 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a Phase II study
Research Article February 5 2025
Factors associated with early quality of life response to palliative care during hematopoietic cell transplantation
Research Article February 5 2025
Intermediate-Dose Post-Transplantation Cyclophosphamide for Myeloablative HLA-Haploidentical Bone Marrow Transplantation
Mustafa A. Hyder,Dimana Dimitrova,Ruby Sabina,Ashley DeVries,Jeannine S. McCune,Meredith J. McAdams,Francis A. Flomerfelt,Christi McKeown,Jennifer L. Sadler,Amy Chai,Thomas E. Hughes,Scott Napier,Anita Stokes,Jennifer Sponaugle,Kamil Rechache,Mark J Parta,Jennifer Cuellar-Rodriguez,William D. Figg,Hyoyoung Choo-Wosoba,Seth M. Steinberg,Jennifer A. Kanakry,Christopher G. Kanakry
Letter February 5 2025
What to do with the WEIGHT while preparing for CAR-T?
Research Article February 5 2025
Glucagon-Like Peptide 1 Receptor Agonists and Venous Thromboembolism in Type 2 Diabetes: A Target Trial Emulation
Letter February 5 2025
